Circulating Tumor DNA as a Marker of Minimal Residual Disease
Cancer Network,
Ben Fangman, MD, and colleagues provide an overview of the use of circulating tumor DNA levels to detect minimal residual…
Ben Fangman, MD, and colleagues provide an overview of the use of circulating tumor DNA levels to detect minimal residual…
Serial postoperative ctDNA analysis could be a useful tool in guiding treatment decisions and improving care for patients with…
Immunotherapy using checkpoint inhibitors can work well to treat cancer, but only a minority of patients respond to therapy.
Immunotherapy using checkpoint inhibitors can work well to treat cancer, but only a minority of patients respond to therapy.